用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-06-29 AccNo: 0001144204-16-110558 Size: 64 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ PRE 14A - Other preliminary proxy statements Filed: 2016-06-15 AccNo: 0001144204-16-108339 Size: 594 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-06-02 AccNo: 0001144204-16-106529 Size: 18 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SD - Filed: 2016-05-31 AccNo: 0001144204-16-105868 Size: 12 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-24 AccNo: 0001144204-16-104550 Size: 19 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-17 AccNo: 0001144204-16-103083 Size: 134 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-16 AccNo: 0001564590-16-019588 Size: 5 MB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-13 AccNo: 0001144204-16-101918 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2016-05-17 09:00 Before Open:NAVIDEA BIOPHAR Earning Release 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-10 AccNo: 0001144204-16-100541 Size: 61 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem ...